Leonid Timashev
Stock Analyst at RBC Capital
(0)
# 4531
Out of 5,319 analysts
73
Total ratings
21.21%
Success rate
-19.41%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
EWTX Edgewise Therapeutic... | Maintains: Outperform | 56 52 | 13.45 | 286.62% | 11 | Apr 3, 2025 | |
PYXS Pyxis Oncology | Reiterates: Outperform | 8 8 | 0.96 | 733.33% | 6 | Mar 19, 2025 | |
INSM Insmed | Reiterates: Outperform | 100 100 | 72.65 | 37.65% | 2 | Mar 19, 2025 | |
BRCC BRC | Maintains: Buy | 3 3 | 2.11 | 42.18% | 1 | Mar 19, 2025 | |
ALKS Alkermes | Initiates Coverage On: Sector Perform | 40 | 27 | 48.15% | 1 | Mar 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 61 61 | 20.37 | 199.46% | 10 | Mar 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 143 192 | 104.46 | 83.8% | 8 | Feb 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 40 40 | 16.34 | 144.8% | 6 | Jan 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Sector Perform | 70 70 | 58.21 | 20.25% | 1 | Jan 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 18 18 | 3.13 | 475.08% | 4 | Jan 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 80 82 | 39.48 | 107.7% | 2 | Dec 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 86 86 | 32.8 | 162.2% | 12 | Dec 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Sector Perform | 4 4 | 3.5 | 14.29% | 8 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sector Perform | 240 20 | n/a | n/a | 1 | Oct 18, 2022 |